Walvax Biotechnology Co., Ltd.

SZSE:300142 Stock Report

Market Cap: CN¥20.0b

Walvax Biotechnology Future Growth

Future criteria checks 3/6

Walvax Biotechnology is forecast to grow earnings and revenue by 54.6% and 11.7% per annum respectively. EPS is expected to grow by 54.4% per annum. Return on equity is forecast to be 6.1% in 3 years.

Key information

54.6%

Earnings growth rate

54.4%

EPS growth rate

Biotechs earnings growth42.6%
Revenue growth rate11.7%
Future return on equity6.1%
Analyst coverage

Low

Last updated29 Oct 2024

Recent future growth updates

Walvax Biotechnology Co., Ltd. (SZSE:300142) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Apr 02
Walvax Biotechnology Co., Ltd. (SZSE:300142) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Recent updates

We Think Walvax Biotechnology (SZSE:300142) Can Stay On Top Of Its Debt

Nov 25
We Think Walvax Biotechnology (SZSE:300142) Can Stay On Top Of Its Debt

Some Confidence Is Lacking In Walvax Biotechnology Co., Ltd.'s (SZSE:300142) P/S

Sep 24
Some Confidence Is Lacking In Walvax Biotechnology Co., Ltd.'s (SZSE:300142) P/S

Is Walvax Biotechnology (SZSE:300142) A Risky Investment?

Jun 19
Is Walvax Biotechnology (SZSE:300142) A Risky Investment?

Walvax Biotechnology Co., Ltd.'s (SZSE:300142) Prospects Need A Boost To Lift Shares

May 23
Walvax Biotechnology Co., Ltd.'s (SZSE:300142) Prospects Need A Boost To Lift Shares

There May Be Reason For Hope In Walvax Biotechnology's (SZSE:300142) Disappointing Earnings

Apr 07
There May Be Reason For Hope In Walvax Biotechnology's (SZSE:300142) Disappointing Earnings

Walvax Biotechnology Co., Ltd. (SZSE:300142) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Apr 02
Walvax Biotechnology Co., Ltd. (SZSE:300142) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Is Walvax Biotechnology (SZSE:300142) A Risky Investment?

Mar 01
Is Walvax Biotechnology (SZSE:300142) A Risky Investment?

Earnings and Revenue Growth Forecasts

SZSE:300142 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,961788N/A8512
12/31/20253,605646N/A1,0062
12/31/20243,114399N/A1,1782
9/30/20243,097122163832N/A
6/30/20243,37913552839N/A
3/31/20243,8802625855N/A
12/31/20234,1144191881,134N/A
9/30/20234,5387512141,191N/A
6/30/20234,9067631581,185N/A
3/31/20235,2648622181,395N/A
1/1/20235,0867291101,201N/A
9/30/20225,0405951601,311N/A
6/30/20224,461530-841,118N/A
3/31/20223,685434-263856N/A
1/1/20223,463428-398705N/A
9/30/20213,501932-660267N/A
6/30/20213,7151,261-525139N/A
3/31/20213,2601,053-45226N/A
12/31/20202,9391,003-293114N/A
9/30/20201,890457-275120N/A
6/30/20201,194119-30384N/A
3/31/20201,05785-34313N/A
12/31/20191,121142-29062N/A
9/30/20191,0981,444-24172N/A
6/30/20191,0001,426-327-44N/A
3/31/20199331,430-265-13N/A
12/31/20188741,415-293-65N/A
9/30/2018807-407-307-81N/A
6/30/2018786-421N/A-62N/A
3/31/2018700-484N/A-14N/A
12/31/2017668-537N/A-10N/A
9/30/2017628265N/A70N/A
6/30/2017555189N/A55N/A
3/31/201746683N/A-33N/A
12/31/201659170N/A-90N/A
9/30/2016692-963N/A-153N/A
6/30/2016885-936N/A-169N/A
3/31/20161,045-835N/A-133N/A
12/31/20151,006-841N/A-69N/A
9/30/2015843182N/A-44N/A
6/30/2015731138N/A-73N/A
3/31/2015705147N/A-16N/A
12/31/2014719143N/A-66N/A
9/30/2014816-139N/A-149N/A
6/30/2014750-91N/A-159N/A
3/31/2014676-29N/A-149N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300142's forecast earnings growth (54.6% per year) is above the savings rate (2.8%).

Earnings vs Market: 300142's earnings (54.6% per year) are forecast to grow faster than the CN market (25.4% per year).

High Growth Earnings: 300142's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300142's revenue (11.7% per year) is forecast to grow slower than the CN market (13.7% per year).

High Growth Revenue: 300142's revenue (11.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300142's Return on Equity is forecast to be low in 3 years time (6.1%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/31 11:34
End of Day Share Price 2024/12/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Walvax Biotechnology Co., Ltd. is covered by 16 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Tong ZhangChina Merchants Securities Co. Ltd.
Ling Bo TuChina Minzu Securities